Small molecule · developed by Sagimet Biosciences
TVB-3567 is an orally administered capsule studied in acne vulgaris.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT06989840 | Phase 1 | Acne | Recruiting | SGMT |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acne
Updated Nov 1, 2026. Something wrong or missing? Report it on the SGMT page.
See SGMT's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SGMT catalysts and pipeline →